Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes

Journal of Clinical Investigation

Volumn 104, Issue 6, 1999, Pages 733-741

  Kim, Young Bum ^a   Nikoulina, Svetlana E ^b   Ciaraldi, Theodore P ^b   Henry, Robert R ^b   Kahn, Barbara B ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVATION; GLUCOSE METABOLISM; HUMAN; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SKELETAL MUSCLE;

EID: 0032698470     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6928     Document Type: Article

References (65)

1. DeFronzo, R.A., Bonadonna, R.C., and Ferrannini, E. 1992. Pathogenesis of NIDDM. A balanced overview. Diabetes Care. 15:318-368.
2. Kahn, B.B. 1998. Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance. Cell. 92:593-596.
3. Yki-Jarvinen, H., Sahlin, K., Ren, J.M., and Koivisto, V.A. 1990. Localization of rate-limiting defect for glucose disposal in skeletal muscle of insulin-resistant type I diabetic patients. Diabetes. 39:157-167.
4. Heesom, K.J., Harbeck, M., Kahn, C.R., and Denton, R.M. 1997. Insulin action on metabolism. Diabetologia. 40:B3-B9.
5. White, M.F. 1997. The insulin signalling system and the IRS proreins. Diabetologia. 40:S2-S17.
6. Zierath, J.R., et al. 1996. Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM. Diabetologia. 39:1180-1189.
7. Zierath, J.R., Houseknecht, K.L., and Kahn, B.B. 1996. Glucose transporters and diabetes. Semin. Cell Dev. Biol. 7:295-307.
8. Carey, J.O., Azevedo, J., Jr., Morris, P.G., Pories, W.J., and Dohm, G.L. 1995. Okadaic acid, vanadate, and phenylarsine oxide stimulate 2-deoxyglucose transport in insulin-resistant human skeletal muscle. Diabetes. 44:682-688.
9. Bjornholm, M., Kawano, Y., Lehnhet, M., and Zierath, J.R. 1997. Insulin receptor substrate-1 phosphorylation and phosphatidylinosirol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes. 46:524-527.
10. Myers, M.G., Jr., and White, M.F. 1996. Insulin signal transduction and the IRS proteins. Annu. Rev. Pharmacol. Toxicol. 36:615-658.
11. Holman, G.D., and Kasuga, M. 1997. From receptor to transporter: insulin signalling to glucose transport. Diabetologia. 40:991-1003.
12. Lavan, B.E., et al. 1997. A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family. J. Biol. Chem. 272:21403-21407.
13. Lavan, B.E., Lane, W.S., and Lienhard, G.E. 1997. The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. J. Biol. Chem. 272:11439-11443.
14. Cheatham, B., et al. 1994. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol. Cell. Biol. 14:4902-4911.
15. Okada, T., Kawano, Y., Sakakibara, T., Hazeki, O., and Ui, M. 1994. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. J. Biol. Chem. 269:3568-3573.
16. Le Marchand-Brustel, Y., Gautier, N., Cormont, M., and Van Obberghen, E. 1995. Wortmannin inhibits the action of insulin but not that of okadaic acid in skeletal muscle: comparison with fat cells. Endocrinology. 136:3564-3570.
17. Hara, K., et al. 1994. 1-phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells. Proc Natl. Acad. Sci. USA. 91:7415-7419.
18. Shepherd, P.R., Nave, B.T., and Siddle, K. 1995. Insulin stimulation of glycogen synthesis and glycogen synthase activity is blocked by wortmannin and rapamycin in 3T3-L1 adipocytes: evidence for the involvement of phosphoinositide 3-kinase and p70 ribosomal protein-S6 kinase. Biochem. J. 305:25-28.
19. Mendez, R., Myers, M., Jr., White, M.F., and Rhoads, R.E. 1996. Stimulation of protein synthesis, eukaryotic translation initiation factor 4E phosphorylation, and PHAS-I phosphorylation by insulin requires insulin receptor substrate 1 and phosphatidylinositol 3-kinase. Mol. Cell. Biol. 16:2857-2864.
20. Sutherland, C., Waltner-Law, M., Gnudi, L., Kahn, B.B., and Granner, D.K. 1998. Activation of the ras mitogen-activated protein kinase-ribosomal protein kinase pathway is not required for the repression of phosphoenolpyruvate carboxykinase gene transcription by insulin. J. Biol. Chem. 273:3198-3204.
21. Frevert, E.U., and Kahn, B.B. 1997. Differential effects of constitutively active phosphatidylinositol 3-kinase on glucose transport, glycogen synthase activity, and DNA synthesis in 3T3-L1 adipocytes. Mol. Cell. Biol. 17:190-198.
22. Tanti, J.F., et al. 1996. Overexpression of a constitutively active form of phosphatidylinositol 3-kinase is sufficient to promote Glut 4 translocation in adipocytes. J. Biol. Chem. 271:25227-25232.
23. Bellacosa, A., Testa, J.R., Staal, S.P., and Tsichlis, P.N. 1991. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science. 254:274-277.
24. Franke, T.F., Tartof, K.D., and Tsichlis, P.N. 1994. The SH2-like Akt homology (AH) domain of c-akt is present in multiple copies in the genome of vertebrate and invertebrate eukaryotes. Cloning and characterization of the Drosophila melanogaster c-akt homolog Dakt1. Oncogene. 9:141-148.
25. Sakaue, H., et al. 1997. Phosphoinositide 3-kinase is required for insulin-induced but not for growth hormone-or hyperosmolarity-induced glucose uptake in 3T3-L1 adipocytes. Mol. Endocrinol. 11:1552-1562.
26. Moule, S.K., et al. 1997. Regulation of protein kinase B and glycogen synthase kinase-3 by insulin and beta-adrenergic agonists in rat epididymal fat cells. Activation of protein kinase B by wortmannin-sensitive and -insensitive mechanisms. J. Biol. Chem. 272:7713-7719.
27. Konishi, H., et al. 1996. Activation of RAC-protein kinase by heat shock and hyperosmolarity stress through a pathway independent of phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. USA. 93:7639-7643.
28. Alessi, D.R., and Cohen, P. 1998. Mechanism of activation and function of protein kinase B. Curr. Opin. Genet. Dev. 8:55-62.
29. Alessi, D.R., et al. 1997. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B alpha. Curr. Biol. 7:261-269.
30. Walker, K.S., et al. 1998. Activation of protein kinase B beta and gamma isoforms by insulin in vivo and by 3-phosphoinositide-dependent protein kinase-1 in vitro: comparison with protein kinase B alpha. Biochem. J. 331:299-308.
31. Franke, T.F., Kaplan, D.R., and Cantley, L.C. 1997. P13K: downstream AKT ion blocks apoptosis. Cell. 88:435-437.
32. Kitamura, T., et al. 1998. Requirement for activation of the serine-threonine kinase akt (protein kinase B) in insulin stimulation of protein synthesis but not of glucose transport. Mol. Cell. Biol. 18:3708-3717.
33. Hajduch, E., Alessi, D.R., Hemmings, B.A., and Hundal, H.S. 1998. Constitutive activation of protein kinase B alpha by membrane targeting promotes glucose and system A amino acid transport, protein synthesis, and inactivation of glycogen synthase kinase 3 in L6 muscle cells. Diabetes. 47:1006-1013.
34. Cross, D.A., Alessi, D.R., Cohen, P., Andjelkovich, M., and Hemmings, B.A. 1995. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 378:785-789.
35. Cohen, P. 1985. The role of protein phosphorylation in the hormonal control of enzyme activity. Eur. J. Biochem. 151:439-448.
36. Kahn, A.D., Takeuchi, F., and Roth, R.A. 1996. Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation. J. Biol. Chem. 271:21920-21926.
37. Cong, L., et al. 1997. Physiological role of Akt in insulin-stimulated translocation of GLUT4 in transfected rat adipose cells. Mol. Endocrinol. 11:1881-1890.
38. Wang, Q., et al. 1999. Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol. Cell. Biol. 19:4008-4018.
39. Ueki, K., et al. 1998. Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis. J. Biol. Chem. 273:5315-5322.
40. Krook, A., Roth, R.A., Jiang, X.J., Zierath, J.R., and Wallberg-Henriksson, H. 1998. Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects. Diabetes. 47:1281-1286.
41. 1998. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 21(Suppl. 1):S5-S22.
42. Thorburn, A.W., Gumbiner, B., Bulacan, F., Brechtel, G., and Henry, R.R. 1991. Multiple defects in muscle glycogen synthase activity contribute to reduced glycogen synthesis in non-insulin dependent diabetes mellitus. J. Clin. Invest. 87:489-495.
43. Goodyear, L.J., et al. 1995. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J. Clin. Invest. 95:2195-2204.
44. Tanti, J.F., et al. 1997. Potential role of protein kinase B in glucose transporter 4 translocation in adipocytes. Endocrinology. 138:2005-2010.
45. Thorburn, A.W., Gumbiner, B., Bulacan, F., Wallace, P., and Henry, R.R. 1990. Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake. J. Clin. Invest. 85:522-529.
46. Henry, R.R., Abrams, L., Nikoulina, S., and Ciaraldi, T.P. 1995. Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures. Diabetes. 44:936-946.
47. Roach, R.J., and Larner, J. 1977. Covalent phosphorylation in the regulation glycogen synthase activity. Mol. Cell. Biochem. 15:179-200.
48. Kohn, A.D., Kovacina, K.S., and Roth, R.A. 1995. Insulin stimulates the kinase activity of RAC-PK, a pleckstrin homology domain containing ser/thr kinase. EMBO J. 14:4288-4295.
49. Mandarino, L.J., Consoli, A., Jain, A., and Kelley, D.E. 1996. Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM. Am. J. Physiol. 270:E463-E470.
50. Johnson, A.B., et al. 1991. Impaired activation of skeletal muscle glycogen synthase in non-insulin-dependent diabetes mellitus is unrelated to the degree of obesity. Metabolism. 40:252-260.
51. Damsbo, P., Vaag, A., Hother-Nielsen, O., and Beck-Nielsen, H. 1991. Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 34:239-245.
52. Cheatham, B., and Kahn, C.R. 1995. Insulin action and the insulin signaling network. Endocr. Rev. 16:117-142.
53. Cross, D.A., et al. 1997. Insulin activates protein kinase B, inhibits glycogen synthase kinase-3 and activates glycogen synthase by rapamycin-insensitive pathways in skeletal muscle and adipose tissue. FEBS Lett. 406:211-215.
54. Kim, Y.-B., et al. 1999. Glucosamine infusion in rats rapidly impairs insulin stimulation of phosphoinositol 3-kinase but does not alter activation of Akt/protein kinase B in skeletal muscle. Diabetes. 48:310-320.
55. Krook, A., et al. 1997. Improved glucose tolerance restores insulin-stimulated Akt kinase activity and glucose transport in skeletal muscle from diabetic Goto-Kakizaki rats. Diabetes. 46:2110-2114.
56. Song, X.M., et al. 1999. Muscle fiber type-specific defects in insulin signal transduction to glucose transport in diabetic GK rats. Diabetes. 48:664-670.
57. Ceresa, B.P., Kao, A.W., Santeler, S.R., and Pessin J.E. 1998. Inhibition of clathrin-mediated endocytosis selectively attenuates specific insulin receptor signal transduction pathways. Mol. Cell. Biol 18:3862-3870.
58. Yano, S., Tokumistu, H., and Soderling, T.R. 1998. Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway. Nature. 396:584-587.
59. Kerouz, N.J., Horsch, D., Pons, S., and Kahn, C.R. 1997. Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse. J. Clin. Invest. 100:3164-3172.
60. Jullien, D., Heydrick, S.J., Gautier, N., Van Obberghen, E., and Le Marchand-Brustel, Y. 1996. Effect of IGF-1 on phosphatidylinositol 3-kinase in soleus muscle of lean and insulin-resistant obese mice. Diabetes. 45:869-875.
61. Withers, D.J., et al. 1998. Disruption of IRS-2 causes type 2 diabetes in mice. Nature. 391:900-904.
62. Previs, S.F., Ren, J.-M., White, M.F., and Shulman, G.I. 1999. Contrasting effects of IRS1 vs. IRS2 gene disruption on carbohydrate and lipid metabolism in vitro. Diabetes. 48(Suppl. 1):A51. (Abstr.)
63. Stambolic, V., et al. 1998. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell. 95:29-39.
64. Heydrick, S.J., et al. 1993. Defect in skeletal muscle phosphatidylinositol-3-kinase in obese insulin-resistant mice. J. Clin. Invest 91:1358-1366.
65. Hickey, M.S., et al. 1997. Insulin activation of phosphatidylinositol 3-kinase in human skeletal muscle in vivo. J. Appl. Physiol. 83:718-722.